Application of therapeutic hemapheresis and the adverse reactions
Journal Title: Chinese Journal of Blood Transfusion - Year 2024, Vol 37, Issue 10
Abstract
Objective To discuss the application of therapeutic hemapheresis in clinical therapy and to observe the adverse reactions. Methods 126 times of therapeutic hemapheresis were performed in 121 patients by Nangel blood cell separator. Consumables and apheresis procedures were selected according to different treatment needs of patients. The clinical therapeutic efficacy laboratory indicators and adverse reactions during the treatment process were analyzed, and corresponding measures were taken. Results Among 100 patients who underwent platelet rich plasma (PRP) treatment, the success rate of collection was 98%. The average PRP platelet level achieved (981.22±3.55)×109/L, and the average concentration multiple of PRP achieved (4.01±0.52) times. All patients obtain symptomatic relief after treatment with PRP. The level of hemoglobin and red blood cell count of 6 polycythemia vera patients and the level of platelet of 10 essential thrombocythemia patients all decreased after therapeutic hemapheresis combined with hydroxycarbamide, with significant difference (P<0.05). Five patients with preoperative autologous blood donation have been through the surgery successfully. Out of the 121 patients, 10(8.26%) experienced mild adverse reaction (8.26%), 15(12.40%) showed bruising and bleeding at puncture site, and 1(0.83%) had pseudoaneurysm. Conclusion Therapeutic hemapheresis has the advantages of good curative effect, high success rate and low incidence of adverse reactions, and can be applied in PRP collection, removal of blood pathological components and preoperative autologous blood donation.
Authors and Affiliations
Qiong WANG, Xiaofang LI, Lu LI, Zhangyong HE
Keywords
Related Articles
- EP ID EP749844
- DOI 10.13303/j.cjbt.issn.1004-549x.2024.10.015
- Views 45
- Downloads 0
Preliminary study on HUVEC permeability changes in FNAIT induced by CD36 antibody
Objective To explore the pathogenesis of fetal edema caused by CD36 antibody in fetal/neonatal alloimmune thrombocytopenia (FNAIT), and to provide reference for clinical prevention and treatment. Methods The established...
The establishment and application of anemergency recruitment strategy for blood donors in Shenzhen under public health emergencies
Objective To establish and improve the emergency recruitment strategy of voluntary blood donors under public health emergencies in Shenzhen and verify its effectiveness. Methods Blood donor recruitment strategies under r...
Research progress of IgM-enriched human intravenous immunoglobulin products
Comparing with conventional human intravenous immunoglobulin products (hIVIG), IgM-enriched hIVIG have more advantages in the neutralization of pathogens and related toxins, the regulation of complement activity, secreti...
Diagnosis and treatment recommendations and case study of severe thrombocytopenia caused by tirofiban
Objective To investigate the clinical manifestations, diagnosis, differential diagnosis and management strategies of thrombocytopenia caused by tirofiban. Methods The basic clinical data, platelet count changes and treat...
Prediction of B cell epitopes of CD36 and preparation of MAP
Objective To analyze the structure of CD36, search the possible B cell epitopes and prepare multi-antigen peptides(MAP) with B cell epitopes, so as to provide a preliminary experimental basis for the preparation of CD36...